Kang Jun Cho1, Kyu-Sung Lee2, Myung-Soo Choo3, Ju Tae Seo4, Jang Hwan Kim5, Jong Bo Choi6, Seung-June Oh7, Joon Chul Kim8. 1. Department of Urology, Bucheon St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. 2. Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. 3. Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. 4. Department of Urology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea. 5. Department of Urology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. 6. Department of Urology, Ajou University Hospital, Ajou University School of Medicine, Suwon, Korea. 7. Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. 8. Department of Urology, Bucheon St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. kjc@catholic.ac.kr.
Abstract
INTRODUCTION AND HYPOTHESIS: The objective was to investigate the expression of endothelial nitric oxide synthase (eNOS) and phosphodiesterase (PDE) 5 in vaginal tissue of premenopausal women experiencing stress urinary incontinence (SUI) with and without sexual dysfunction. METHODS: Women presenting for treatment of SUI were screened using the Female Sexual Function Index (FSFI) and 10 were selected who met the criteria for female sexual dysfunction (FSD) and 10 asymptomatic controls. Vaginal tissue specimens were obtained from those premenopausal women aged ≥40 years who had had sexual activity ≥2 times every month for the last 6 months and who were scheduled to undergo surgery for SUI. FSD criteria was FSFI scores <18 and arousal domain scores <3. The control group had FSFI scores ≥26 and individual domain scores ≥4. The expressions of eNOS and PDE 5 were compared in the two groups using immunofluorescence staining and western blotting. RESULTS: The mean total FSFI scores were 30.4 ± 2.6 and 15.3 ± 2.3 in the control and FSD groups respectively. In immunofluorescence staining, eNOS and PDE5 were localized in the vaginal epithelium. In western blotting, the expressions of eNOS and PDE5 were significantly lower in the FSD group than in the control group (p = 0.003 and p = 0.038 respectively). CONCLUSIONS: eNOS and PDE5 in the vagina may play important roles in the pathophysiology of FSD.
INTRODUCTION AND HYPOTHESIS: The objective was to investigate the expression of endothelial nitric oxide synthase (eNOS) and phosphodiesterase (PDE) 5 in vaginal tissue of premenopausal women experiencing stress urinary incontinence (SUI) with and without sexual dysfunction. METHODS:Women presenting for treatment of SUI were screened using the Female Sexual Function Index (FSFI) and 10 were selected who met the criteria for female sexual dysfunction (FSD) and 10 asymptomatic controls. Vaginal tissue specimens were obtained from those premenopausal women aged ≥40 years who had had sexual activity ≥2 times every month for the last 6 months and who were scheduled to undergo surgery for SUI. FSD criteria was FSFI scores <18 and arousal domain scores <3. The control group had FSFI scores ≥26 and individual domain scores ≥4. The expressions of eNOS and PDE 5 were compared in the two groups using immunofluorescence staining and western blotting. RESULTS: The mean total FSFI scores were 30.4 ± 2.6 and 15.3 ± 2.3 in the control and FSD groups respectively. In immunofluorescence staining, eNOS and PDE5 were localized in the vaginal epithelium. In western blotting, the expressions of eNOS and PDE5 were significantly lower in the FSD group than in the control group (p = 0.003 and p = 0.038 respectively). CONCLUSIONS:eNOS and PDE5 in the vagina may play important roles in the pathophysiology of FSD.
Authors: Maurizio Baldassarre; Stefania Alvisi; Marta Berra; Valentina Martelli; Antonio Farina; Alberto Righi; Maria Cristina Meriggiola Journal: J Sex Med Date: 2015-05-14 Impact factor: 3.802
Authors: Biljana Musicki; Tongyun Liu; Travis D Strong; Gwen A Lagoda; Trinity J Bivalacqua; Arthur L Burnett Journal: J Sex Med Date: 2010-03-11 Impact factor: 3.802
Authors: I Cellai; S Filippi; P Comeglio; S Cipriani; E Maseroli; V Di Stasi; T Todisco; S Marchiani; L Tamburrino; F Villanelli; S Vezzani; C Corno; M Fambrini; G Guarnieri; E Sarchielli; A Morelli; G Rastrelli; M Maggi; L Vignozzi Journal: J Endocrinol Invest Date: 2022-01-24 Impact factor: 5.467